Form 4: Vigil Neuroscience Director Suzanne Bruhn Receives Stock Option Award

Director Suzanne Louise Bruhn of Vigil Neuroscience, Inc. was granted a stock option award for 18,068 shares on June 5, 2024.

Summary

• Suzanne Louise Bruhn, a director at Vigil Neuroscience, Inc., received a stock option award on June 5, 2024.
• The award is for 18,068 shares of common stock.
• The exercise price of the stock option is $3.38.
• The options vest on the earlier of June 5, 2025, or the next annual meeting of the Issuer's stockholders.
• The option expires on June 5, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a routine part of executive compensation and aligns the director's interests with shareholders. There are no red flags or negative implications in the filing.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.

Industry Context

Stock option awards are a common form of executive compensation in the biotechnology industry, used to incentivize performance and align management interests with those of shareholders. This grant is a standard practice for compensating board members.

Comparison to Industry Standards

• Stock option grants are a typical component of compensation packages for directors in publicly traded companies, particularly in the biotech sector.
• The size of the grant (18,068 shares) and the vesting schedule (one year or next annual meeting) appear to be within the typical range for director compensation at companies of Vigil Neuroscience's size and stage.
• Comparable companies in the biotech industry, such as Biohaven or Amylyx Pharmaceuticals, often use similar stock option plans to incentivize their directors and key employees.

Stakeholder Impact

• The stock option award aligns the director's interests with those of the shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates